We are live on ! Find out more
NEPH icon

Nephros
NEPH

16 hedge funds and large institutions have $3.36M invested in Nephros in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 17 → 16 (-1)

8.87% less ownership

Funds ownership: 50.85% → 41.98% (-8.9%)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

66% less capital invested

Capital invested by funds: $9.8M → $3.36M (-$6.44M)

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
7
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$96.4K
2
BA
Bard Associates
Illinois
+$66K
3
WC
Wexford Capital
Florida
+$63.8K
4
CF
Cantor Fitzgerald
New York
+$60.8K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$48.4K

Top Sellers

Rank Fund Capital Flow
1
CPA
Cowen Prime Advisors
New York
-$2.62M
2
SC
Samjo Capital
New York
-$2.51M
3
TCWM
Total Clarity Wealth Management
Illinois
-$4K
4
BlackRock
BlackRock
New York
-$3.51K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$1.08M +$66K +13,900 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$541K – – –
WC
3
Wexford Capital
Florida
$534K +$63.8K +13,440 +0.4%
CPA
4
Cowen Prime Advisors
New York
$354K -$2.62M -552,650 -87%
HighTower Advisors
5
HighTower Advisors
Illinois
$245K – – –
William Blair & Company
6
William Blair & Company
Illinois
$159K – – –
EP
7
Elkhorn Partners
Nebraska
$104K +$40.4K +8,512 +56%
Renaissance Technologies
8
Renaissance Technologies
New York
$89K +$96.4K +20,317 New
BlackRock
9
BlackRock
New York
$78K -$3.51K -739 -4%
CF
10
Cantor Fitzgerald
New York
$56K +$60.8K +12,813 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$44K +$48.4K +10,192 New
Osaic Holdings
12
Osaic Holdings
Arizona
$38K +$19.5K +4,100 +90%
Morgan Stanley
13
Morgan Stanley
New York
$33K +$4.98K +1,049 +16%
TRCT
14
Tower Research Capital (TRC)
New York
$2K +$1.76K +371 +482%
SC
15
Samjo Capital
New York
– -$2.51M -425,000 Closed
TCWM
16
Total Clarity Wealth Management
Illinois
– -$4K -715 Closed
Fidelity Investments
17
Fidelity Investments
Massachusetts
– -$1K -91 Closed
Wells Fargo
18
Wells Fargo
California
– +$5 +1 +2%

NEPH Hedge Fund Activity: Q1 2022 in Review

16 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q1 2022, worth a combined $3.36M — down 66% from $9.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NEPH and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $96.4K. The largest seller was Cowen Prime Advisors, cutting an estimated $2.62M.

  • 16 institutional investors held Nephros (NEPH) as of Q1 2022, down from 17 in Q4 2021.
  • Funds reported $3.36M of Nephros stock for Q1 2022, down 66% quarter-over-quarter.
  • 3 funds opened new Nephros positions in Q1 2022 and 4 closed out, a net change of -1 holder.
  • The largest Nephros buyer in Q1 2022 was Renaissance Technologies, an estimated $96.4K added.
  • The largest Nephros seller in Q1 2022 was Cowen Prime Advisors, an estimated $2.62M sold.

Based on aggregated 13F filings for Q1 2022.